Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Illumina, Inc. (NASDAQ:ILMN) will announce its second quarter 2022 financial results after market close on August 11, 2022. A conference call will be held at 2:00 PM PT to discuss these results, featuring CEO Francis deSouza and CFO Joydeep Goswami. Investors can join via Illumina's website or by dialing in. The replay will be available for 30 days post-event. Illumina focuses on advancing healthcare through genomic solutions, catering to life sciences, clinical, and applied markets.
- Scheduled announcement of financial results demonstrates transparency.
- Conference call provides a platform for investor engagement.
- None.
SAN DIEGO, July 14, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2022 following the close of market on Thursday, August 11, 2022.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, Chief Executive Officer, and Joydeep Goswami, Chief Strategy and Corporate Development Officer and Interim Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 11, 2022. Interested parties may access the live teleconference through the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. Alternatively, individuals can access the call by dialing 866.409.1555 or +1.313.209.4906 outside North America, both with Conference ID 6659694. To ensure timely connection, please dial in at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Sarah Shew
+1.858.336.3157
sshew@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-second-quarter-2022-financial-results-on-thursday-august-11-2022-301587055.html
SOURCE Illumina, Inc.
FAQ
When will Illumina release its Q2 2022 earnings?
What time is the Illumina Q2 2022 conference call?
How can I access Illumina's conference call?
Who will be presenting during the Illumina Q2 earnings call?